EDWARDS LIFESCIENCES CORP (1EW.MI) Fundamental Analysis & Valuation
BIT:1EW • US28176E1082
Current stock price
65.35 EUR
-5.41 (-7.65%)
Last:
This 1EW.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. 1EW.MI Profitability Analysis
1.1 Basic Checks
- 1EW had positive earnings in the past year.
- 1EW had a positive operating cash flow in the past year.
- In the past 5 years 1EW has always been profitable.
- Each year in the past 5 years 1EW had a positive operating cash flow.
1.2 Ratios
- 1EW has a better Return On Assets (10.31%) than 89.55% of its industry peers.
- The Return On Equity of 1EW (13.40%) is better than 77.61% of its industry peers.
- 1EW's Return On Invested Capital of 12.50% is amongst the best of the industry. 1EW outperforms 89.55% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for 1EW is significantly above the industry average of 10.72%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.31% | ||
| ROE | 13.4% | ||
| ROIC | 12.5% |
ROA(3y)21.77%
ROA(5y)18.87%
ROE(3y)29.68%
ROE(5y)26.56%
ROIC(3y)15.82%
ROIC(5y)17.27%
1.3 Margins
- The Profit Margin of 1EW (23.25%) is better than 92.54% of its industry peers.
- 1EW's Profit Margin has improved in the last couple of years.
- The Operating Margin of 1EW (27.73%) is better than 97.01% of its industry peers.
- 1EW's Operating Margin has been stable in the last couple of years.
- 1EW has a better Gross Margin (78.19%) than 92.54% of its industry peers.
- In the last couple of years the Gross Margin of 1EW has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 27.73% | ||
| PM (TTM) | 23.25% | ||
| GM | 78.19% |
OM growth 3Y-5.94%
OM growth 5Y-1.04%
PM growth 3Y38.76%
PM growth 5Y26.09%
GM growth 3Y1.43%
GM growth 5Y1.33%
2. 1EW.MI Health Analysis
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), 1EW is creating some value.
- The number of shares outstanding for 1EW has been reduced compared to 1 year ago.
- The number of shares outstanding for 1EW has been reduced compared to 5 years ago.
- 1EW has a better debt/assets ratio than last year.
2.2 Solvency
- 1EW has an Altman-Z score of 11.49. This indicates that 1EW is financially healthy and has little risk of bankruptcy at the moment.
- 1EW has a better Altman-Z score (11.49) than 92.54% of its industry peers.
- 1EW has a debt to FCF ratio of 0.75. This is a very positive value and a sign of high solvency as it would only need 0.75 years to pay back of all of its debts.
- 1EW's Debt to FCF ratio of 0.75 is amongst the best of the industry. 1EW outperforms 91.04% of its industry peers.
- A Debt/Equity ratio of 0.06 indicates that 1EW is not too dependend on debt financing.
- 1EW's Debt to Equity ratio of 0.06 is amongst the best of the industry. 1EW outperforms 85.07% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.06 | ||
| Debt/FCF | 0.75 | ||
| Altman-Z | 11.49 |
ROIC/WACC1.25
WACC9.99%
2.3 Liquidity
- 1EW has a Current Ratio of 4.00. This indicates that 1EW is financially healthy and has no problem in meeting its short term obligations.
- The Current ratio of 1EW (4.00) is better than 92.54% of its industry peers.
- A Quick Ratio of 3.29 indicates that 1EW has no problem at all paying its short term obligations.
- 1EW has a Quick ratio of 3.29. This is amongst the best in the industry. 1EW outperforms 92.54% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4 | ||
| Quick Ratio | 3.29 |
3. 1EW.MI Growth Analysis
3.1 Past
- The earnings per share for 1EW have decreased by -3.75% in the last year.
- Measured over the past 5 years, 1EW shows a small growth in Earnings Per Share. The EPS has been growing by 7.13% on average per year.
- Looking at the last year, 1EW shows a small growth in Revenue. The Revenue has grown by 4.67% in the last year.
- The Revenue has been growing slightly by 4.58% on average over the past years.
EPS 1Y (TTM)-3.75%
EPS 3Y5.52%
EPS 5Y7.13%
EPS Q2Q%0%
Revenue 1Y (TTM)4.67%
Revenue growth 3Y1.3%
Revenue growth 5Y4.58%
Sales Q2Q%14.67%
3.2 Future
- Based on estimates for the next years, 1EW will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.40% on average per year.
- 1EW is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.47% yearly.
EPS Next Y1.27%
EPS Next 2Y6.53%
EPS Next 3Y7.87%
EPS Next 5Y9.4%
Revenue Next Year4.63%
Revenue Next 2Y7.15%
Revenue Next 3Y8.06%
Revenue Next 5Y8.47%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. 1EW.MI Valuation Analysis
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 29.84 indicates a quite expensive valuation of 1EW.
- The rest of the industry has a similar Price/Earnings ratio as 1EW.
- When comparing the Price/Earnings ratio of 1EW to the average of the S&P500 Index (25.70), we can say 1EW is valued inline with the index average.
- With a Price/Forward Earnings ratio of 25.83, 1EW can be considered very expensive at the moment.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of 1EW is on the same level as its industry peers.
- 1EW is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 23.84, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.84 | ||
| Fwd PE | 25.83 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 1EW indicates a slightly more expensive valuation: 1EW is more expensive than 61.19% of the companies listed in the same industry.
- The rest of the industry has a similar Price/Free Cash Flow ratio as 1EW.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 55.74 | ||
| EV/EBITDA | 22.46 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
- 1EW has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)23.47
PEG (5Y)4.18
EPS Next 2Y6.53%
EPS Next 3Y7.87%
5. 1EW.MI Dividend Analysis
5.1 Amount
- 1EW does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
1EW.MI Fundamentals: All Metrics, Ratios and Statistics
BIT:1EW (2/10/2026, 7:00:00 PM)
65.35
-5.41 (-7.65%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-30 2025-10-30/amc
Earnings (Next)02-10 2026-02-10/amc
Inst Owners89.94%
Inst Owner ChangeN/A
Ins Owners0.11%
Ins Owner ChangeN/A
Market Cap37.92B
Revenue(TTM)5.88B
Net Income(TTM)1.37B
Analysts79.52
Price Target82.88 (26.82%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.01%
Min EPS beat(2)4.4%
Max EPS beat(2)9.63%
EPS beat(4)4
Avg EPS beat(4)5.38%
Min EPS beat(4)3.4%
Max EPS beat(4)9.63%
EPS beat(8)5
Avg EPS beat(8)2.27%
EPS beat(12)6
Avg EPS beat(12)1.21%
EPS beat(16)7
Avg EPS beat(16)-0.18%
Revenue beat(2)1
Avg Revenue beat(2)0.37%
Min Revenue beat(2)-0.12%
Max Revenue beat(2)0.85%
Revenue beat(4)1
Avg Revenue beat(4)-0.56%
Min Revenue beat(4)-2.1%
Max Revenue beat(4)0.85%
Revenue beat(8)1
Avg Revenue beat(8)-4.64%
Revenue beat(12)2
Avg Revenue beat(12)-3.41%
Revenue beat(16)2
Avg Revenue beat(16)-3.45%
PT rev (1m)1.89%
PT rev (3m)7%
EPS NQ rev (1m)-0.25%
EPS NQ rev (3m)-1.76%
EPS NY rev (1m)0.84%
EPS NY rev (3m)5.07%
Revenue NQ rev (1m)0.31%
Revenue NQ rev (3m)3.04%
Revenue NY rev (1m)0.29%
Revenue NY rev (3m)3.76%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.84 | ||
| Fwd PE | 25.83 | ||
| P/S | 7.58 | ||
| P/FCF | 55.74 | ||
| P/OCF | 43.83 | ||
| P/B | 4.37 | ||
| P/tB | 6.1 | ||
| EV/EBITDA | 22.46 |
EPS(TTM)2.19
EY3.35%
EPS(NY)2.53
Fwd EY3.87%
FCF(TTM)1.17
FCFY1.79%
OCF(TTM)1.49
OCFY2.28%
SpS8.63
BVpS14.96
TBVpS10.71
PEG (NY)23.47
PEG (5Y)4.18
Graham Number27.15
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.31% | ||
| ROE | 13.4% | ||
| ROCE | 13.97% | ||
| ROIC | 12.5% | ||
| ROICexc | 18.63% | ||
| ROICexgc | 29.56% | ||
| OM | 27.73% | ||
| PM (TTM) | 23.25% | ||
| GM | 78.19% | ||
| FCFM | 13.59% |
ROA(3y)21.77%
ROA(5y)18.87%
ROE(3y)29.68%
ROE(5y)26.56%
ROIC(3y)15.82%
ROIC(5y)17.27%
ROICexc(3y)20.51%
ROICexc(5y)22.13%
ROICexgc(3y)29.09%
ROICexgc(5y)31.03%
ROCE(3y)17.66%
ROCE(5y)19.29%
ROICexgc growth 3Y-5.47%
ROICexgc growth 5Y-8.01%
ROICexc growth 3Y-11.82%
ROICexc growth 5Y-8.6%
OM growth 3Y-5.94%
OM growth 5Y-1.04%
PM growth 3Y38.76%
PM growth 5Y26.09%
GM growth 3Y1.43%
GM growth 5Y1.33%
F-Score6
Asset Turnover0.44
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.06 | ||
| Debt/FCF | 0.75 | ||
| Debt/EBITDA | 0.33 | ||
| Cap/Depr | 138.79% | ||
| Cap/Sales | 3.69% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 56.86% | ||
| Profit Quality | 58.45% | ||
| Current Ratio | 4 | ||
| Quick Ratio | 3.29 | ||
| Altman-Z | 11.49 |
F-Score6
WACC9.99%
ROIC/WACC1.25
Cap/Depr(3y)185.14%
Cap/Depr(5y)236.01%
Cap/Sales(3y)5.48%
Cap/Sales(5y)6.41%
Profit Quality(3y)37.92%
Profit Quality(5y)57.13%
High Growth Momentum
Growth
EPS 1Y (TTM)-3.75%
EPS 3Y5.52%
EPS 5Y7.13%
EPS Q2Q%0%
EPS Next Y1.27%
EPS Next 2Y6.53%
EPS Next 3Y7.87%
EPS Next 5Y9.4%
Revenue 1Y (TTM)4.67%
Revenue growth 3Y1.3%
Revenue growth 5Y4.58%
Sales Q2Q%14.67%
Revenue Next Year4.63%
Revenue Next 2Y7.15%
Revenue Next 3Y8.06%
Revenue Next 5Y8.47%
EBIT growth 1Y4.68%
EBIT growth 3Y-4.72%
EBIT growth 5Y3.49%
EBIT Next Year13.12%
EBIT Next 3Y12.54%
EBIT Next 5Y12.3%
FCF growth 1Y1.45%
FCF growth 3Y-42.99%
FCF growth 5Y-22.01%
OCF growth 1Y-2.42%
OCF growth 3Y-32.1%
OCF growth 5Y-14.39%
EDWARDS LIFESCIENCES CORP / 1EW.MI Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for EDWARDS LIFESCIENCES CORP?
ChartMill assigns a fundamental rating of 7 / 10 to 1EW.MI.
What is the valuation status of EDWARDS LIFESCIENCES CORP (1EW.MI) stock?
ChartMill assigns a valuation rating of 2 / 10 to EDWARDS LIFESCIENCES CORP (1EW.MI). This can be considered as Overvalued.
How profitable is EDWARDS LIFESCIENCES CORP (1EW.MI) stock?
EDWARDS LIFESCIENCES CORP (1EW.MI) has a profitability rating of 8 / 10.
What is the valuation of EDWARDS LIFESCIENCES CORP based on its PE and PB ratios?
The Price/Earnings (PE) ratio for EDWARDS LIFESCIENCES CORP (1EW.MI) is 29.84 and the Price/Book (PB) ratio is 4.37.
What is the expected EPS growth for EDWARDS LIFESCIENCES CORP (1EW.MI) stock?
The Earnings per Share (EPS) of EDWARDS LIFESCIENCES CORP (1EW.MI) is expected to grow by 1.27% in the next year.